China distress: After the boom
China’s slowing growth has created a wave of corporate defaults, and these bad debts should be put up for sale. Not all foreign investors are ready to jump in, though, conscious of the difficulties in extracting value
The seeds of China's current bad debt investment opportunity were sown seven years ago. With exports plummeting and consumer confidence wavering in the wake of the global financial crisis, the government...
More on Credit/Special Situations
Latest News
New Frontier Japan targets $94m for second fund
New Frontier Japan Investment (NFJI), a lower middle-market Japanese private equity firm, is looking to raise JPY10 billion ($94.4 million) for its second fund.
Private equity & cybersecurity: Dark clouds
From fraudulent drawdown notices to ransomware, private equity firms and their portfolio companies are increasingly vulnerable to cyber-attacks. Training and vigilance are paramount
China's WuXi Diagnostics raises $150m
WuXi Diagnostics, a joint venture China diagnostics business set up by Hong Kong-listed pharmaceutical outsourcing giant WuXi AppTec and US-based Mayo Clinic has completed a $150 million Series B funding round.
Q&A: Affirma Capital's Ivo Philipps
Affirma Capital came into being 18 months ago as Standard Chartered’s private equity team spun out with most of the remaining balance sheet assets. COO Ivo Philipps explains the middle and back office transition